C-class functions with new approach on coincidence point results for generalized (ψ,φ)-weakly contractions in ordered b-metric spaces

In this paper, by using the C-class functions and a new approach we present some coincidence point results for four mappings satisfying generalized (ψ,φ) -weakly contractive condition in the setting of ordered b-metric spaces. Also, an application and example are given to support our results.Scopu

The global burden of tuberculosis: results from the Global Burden of Disease Study 2015

Background: An understanding of the trends in tuberculosis incidence, prevalence, and mortality is crucial to tracking of the success of tuberculosis control programmes and identification of remaining challenges. We assessed trends in the fatal and non-fatal burden of tuberculosis over the past 25 years for 195 countries and territories. Methods: We analysed 10 691 site-years of vital registration data, 768 site-years of verbal autopsy data, and 361 site-years of mortality surveillance data using the Cause of Death Ensemble model to estimate tuberculosis mortality rates. We analysed all available age-specific and sex-specific data sources, including annual case notifications, prevalence surveys, and estimated cause-specific mortality, to generate internally consistent estimates of incidence, prevalence, and mortality using DisMod-MR 2.1, a Bayesian meta-regression tool. We assessed how observed tuberculosis incidence, prevalence, and mortality differed from expected trends as predicted by the Socio-demographic Index (SDI), a composite indicator based on income per capita, average years of schooling, and total fertility rate. We also estimated tuberculosis mortality and disability-adjusted life-years attributable to the independent effects of risk factors including smoking, alcohol use, and diabetes. Findings: Globally, in 2015, the number of tuberculosis incident cases (including new and relapse cases) was 10·2 million (95% uncertainty interval 9·2 million to 11·5 million), the number of prevalent cases was 10·1 million (9·2 million to 11·1 million), and the number of deaths was 1·3 million (1·1 million to 1·6 million). Among individuals who were HIV negative, the number of incident cases was 8·8 million (8·0 million to 9·9 million), the number of prevalent cases was 8·9 million (8·1 million to 9·7 million), and the number of deaths was 1·1 million (0·9 million to 1·4 million). Annualised rates of change from 2005 to 2015 showed a faster decline in mortality (–4·1% [–5·0 to –3·4]) than in incidence (–1·6% [–1·9 to –1·2]) and prevalence (–0·7% [–1·0 to –0·5]) among HIV-negative individuals. The SDI was inversely associated with HIV-negative mortality rates but did not show a clear gradient for incidence and prevalence. Most of Asia, eastern Europe, and sub-Saharan Africa had higher rates of HIV-negative tuberculosis burden than expected given their SDI. Alcohol use accounted for 11·4% (9·3–13·0) of global tuberculosis deaths among HIV-negative individuals in 2015, diabetes accounted for 10·6% (6·8–14·8), and smoking accounted for 7·8% (3·8–12·0). Interpretation: Despite a concerted global effort to reduce the burden of tuberculosis, it still causes a large disease burden globally. Strengthening of health systems for early detection of tuberculosis and improvement of the quality of tuberculosis care, including prompt and accurate diagnosis, early initiation of treatment, and regular follow-up, are priorities. Countries with higher than expected tuberculosis rates for their level of sociodemographic development should investigate the reasons for lagging behind and take remedial action. Efforts to prevent smoking, alcohol use, and diabetes could also substantially reduce the burden of tuberculosis

Biogenic Silver Nanoparticles Combined with L-Arginine Using Escherichia coli and their Antibacterial and Cytotoxic Activities via ROS Production against A-549 Cells

Background: Silver and its nanoparticles have gained attention owing to their unique physicochemical properties which contribute to their antimicrobial and anticancer properties. The primary focus of this study was the synthesis of silver nanoparticles (AgNPs) using the cell filtrate of Escherichia coli (E. coli) American Type Culture Collection (ATCC) 8739. Methods: Silver nanoparticles were synthesized using E. coli and coated with non-toxic, naturally occurring L-arginine. L-arginine-coated AgNPs (L-AgNPs) were tested for purity, elemental composition, morphology, topology, and stability. Subsequently, they were tested for their antibacterial, apoptotic, reactive oxygen species (ROS), and cytotoxic effects on A549 lung cancer cells using the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Results: The study revealed the formation of well-defined nanoparticles with a spherical shape, falling within the size range of 8.8 nm to 44.6 nm. The L-AgNPs exhibited significant antibacterial characteristics, with the largest zone of inhibition observed against Salmonella spp. (18.7 ± 0.9 mm) and the smallest against Bacillus cereus (8.7 ± 0.9 mm). The half maximal inhibitory concentration (IC50) value of L-AgNPs against A549 lung cancer cells was 58.67 μg/mL, while against 3T3-L1 cells, it was measured as 98.03 μg/mL via MTT assay. L-AgNPs induced apoptosis, as confirmed by morphological alterations in the cells, membrane blebbing, and chromatin condensation. These nanoparticles also triggered the production of reactive oxygen species (ROS) due to cellular oxidative stress, as indicated by the increased levels of dichlorodihydrofluorescein (DCF). Conclusion: This research demonstrates the potential application of these L-AgNPs in the biotechnology and pharmaceutical industries for their antibacterial and anticancer properties

Moringa oleifera Lam. (family Moringaceae) leaf extract attenuates high-fat diet-induced dyslipidemia and vascular endothelium dysfunction in Wistar albino rats

Purpose: To investigate the protective effect of methanol extract of Moringa oleifera leaves (MEMO) in high-fat diet (HFD)-induced dyslipidemia and vascular endothelium dysfunction. Methods: Dose-dependent attenuating effect of MEMO was tested at doses of 200 and 400 mg/kg/day in an in vivo model of HFD-induced dyslipidemia using rats whereas vascular endothelial reactivity was assessed in isolated rat aorta using ex vivo organ bath setup. Results: MEMO administration in HFD-induced dyslipidemic rats for 3 consecutive weeks, resulted in significant decrease in rat body weight, LW/BW and RFPW/BW ratio when compared to rats treated with HFD only where an increase in body weight was observed. Decrease in the average daily feed intake and significant reductions in waist, Lee index and BMI was also observed after MEMO treatment in HFD-induced dyslipidemic rats. Lipid profile data indicate that HFD group showed significant increase in total cholesterol, triglyceride, LDL and VLDL levels while HDL levels decreased significantly. On the other hand, MEMO treatment improved lipid profile compared to HFD group. Ex-vivo isolated aorta results revealed that MEMO treatment reversed HFD-induced endothelium dysfunction when compared to SD group. Conclusion: MEMO treatment produces dose-dependent improvement in lipid profile and vascular endothelium protection, thereby rationalizing its traditional medicine use in the treatment of dyslipidemia and cardiovascular related endothelial disorders

EFFECT OF BETA VULGARIS L. ON CHOLESTEROL RICH DIET-INDUCED HYPERCHOLESTEROLEMIA IN RATS

Abstract The lyophilized aqueous extract of Beta vulgaris L. (beet root) (BVE) was investigated for its possible antihypercholesterolemic and antioxidant potential in cholesterol rich diet-induced hypercholesterolemia in Wistar albino rats. Hypercholesterolemia was induced in rats by feeding 1% cholesterol rich diet for 10 weeks. Lipid profile and glucose were estimated in serum. Malondialdehyde (MDA) and non-protein sulfhydryls (NP-SH) levels were measured in liver and heart. Hypercholesterolemic rats showed a significant increase in total cholesterol and triglycerides and a significant decrease in high-density lipoprotein-cholesterol (HDL-C) levels. BVE at the doses of 250 and 500 mg/kg body weight for 70 consecutive days showed a significant decrease in total cholesterol and triglycerides and significant increase in HDL-C. Furthermore, hypercholesterolemic rats showed free radical generation (lipid peroxidation), evident by a significant increase in MDA level and a significant reduction in NP-SH content in both liver and heart homogenates. BVE treatment significantly decreased MDA level and significantly replenished the reduced NP-SH content in both liver and heart tissue. The acute toxicity test of BVE showed no mortality or morbidity in rats. The findings indicate that BVE has a significant antihypercholesterolemic and antioxidant potential and/or free radical scavenging properties in hypercholesterolemic, rats possibly exerted by the phytoconstituents present in the beet root. Rezumat Studiul experimental evaluează acţiunea antihipercolesterolemiantă şi antioxidantă a extractului apos liofilizat al rădăcinii plantei Beta vulgaris (Chenopodiaceae). Studiul a fost realizat pe şobolani albi de laborator, cărora li s-a indus experimental hipercolesterolemia. A fost evaluat profilul lipidic şi glucidic al animalelor, concentraţia serică a malonildialdehidei. De asemenea, au fost evaluate (ĭn ţesutul hepatic şi cardiac) grupările sulfhidril non-proteice. Rezultatele obţinute indică proprietăţile antihipercolesterolemiante şi antioxidante, datorate fitoconstituenţilor prezenţi în rădăcina plantei studiate

Bacterial contamination of Saudi Arabian paper currency: A report from Al-Kharj

Background: Currency is a public support tool for exchange of commodity and services. It’s prevalent practice for acquiring bread to broast and bath to bed has connected all human being together irrespective of race and occupation. Currency notes along with their denomination values also carry pathogens if contaminated and will act as an agent for infection transference. Therefore the objective of this cross-sectional study was to assess the load microbial pathogens of paper currency collected in selected public places of Al-Kharj, Saudi Arabia.Methods: Currency notes under study were assessed through microbiological culture, microscopic and biochemical visualization techniques.Results: The results from this cross-sectional study suggested that lower the currency denominations higher was the microbial contaminations, frequency percentage was lower with higher isolations. Small eateries were the biggest source of contaminated currency from the ten selected centres. Percentage microorganism occurrence for Bacillus sp., Staphylococcus sp., Klebsiella sp. and E. coli was 56.84%, 25.03%, 13.40% and 04.71% respectively in all currency notes under study.Conclusions: The outcomes of this study revealed that currency notes can be a source for microbe transmission causing infectious diseases represent public health hazards to the community and individuals

Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

Background Comparable data on the global and country-specific burden of neurological disorders and their trends are crucial for health-care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study provides such information but does not routinely aggregate results that are of interest to clinicians specialising in neurological conditions. In this systematic analysis, we quantified the global disease burden due to neurological disorders in 2015 and its relationship with country development level. Methods We estimated global and country-specific prevalence, mortality, disability-adjusted life-years (DALYs), years of life lost (YLLs), and years lived with disability (YLDs) for various neurological disorders that in the GBD classification have been previously spread across multiple disease groupings. The more inclusive grouping of neurological disorders included stroke, meningitis, encephalitis, tetanus, Alzheimer's disease and other dementias, Parkinson's disease, epilepsy, multiple sclerosis, motor neuron disease, migraine, tension-type headache, medication overuse headache, brain and nervous system cancers, and a residual category of other neurological disorders. We also analysed results based on the Socio-demographic Index (SDI), a compound measure of income per capita, education, and fertility, to identify patterns associated with development and how countries fare against expected outcomes relative to their level of development. Findings Neurological disorders ranked as the leading cause group of DALYs in 2015 (250·7 [95% uncertainty interval (UI) 229·1 to 274·7] million, comprising 10·2% of global DALYs) and the second-leading cause group of deaths (9·4 [9·1 to 9·7] million], comprising 16·8% of global deaths). The most prevalent neurological disorders were tension-type headache (1505·9 [UI 1337·3 to 1681·6 million cases]), migraine (958·8 [872·1 to 1055·6] million), medication overuse headache (58·5 [50·8 to 67·4 million]), and Alzheimer's disease and other dementias (46·0 [40·2 to 52·7 million]). Between 1990 and 2015, the number of deaths from neurological disorders increased by 36·7%, and the number of DALYs by 7·4%. These increases occurred despite decreases in age-standardised rates of death and DALYs of 26·1% and 29·7%, respectively; stroke and communicable neurological disorders were responsible for most of these decreases. Communicable neurological disorders were the largest cause of DALYs in countries with low SDI. Stroke rates were highest at middle levels of SDI and lowest at the highest SDI. Most of the changes in DALY rates of neurological disorders with development were driven by changes in YLLs. Interpretation Neurological disorders are an important cause of disability and death worldwide. Globally, the burden of neurological disorders has increased substantially over the past 25 years because of expanding population numbers and ageing, despite substantial decreases in mortality rates from stroke and communicable neurological disorders. The number of patients who will need care by clinicians with expertise in neurological conditions will continue to grow in coming decades. Policy makers and health-care providers should be aware of these trends to provide adequate services